The most common complication of inserting a temporary hemodialysis catheter was catheter-related bloodstreaminfections (CRB SIs). The purpose of this study was to control the CRBSIs effectively. This study incorporated with a cross-sectional design involving field observation and retrospective chart review for 9 months, collecting 101 cases. The CRBSIs rate was 9.35%. From 14 CRBSI cases collected, we found that the incidence of an abnormal insertion site was 71.4% and the average number of days for abnormal insertion site was 4.79±5.3 days. The incidence of fever was 85.7% and the average occurrence days for fever were 6±5.3 days. The result showed that an increased number of catheter insertions, corresponded to higher WBC data before catheter removal and higher incidence of a fever episode, making a significant statistical difference between the CRBSIs and non-CRBSIs group (p<.05). The average length of stay for CRBSIs was 7.8 days longer than non-CRBSIs group. Therefore, controlling the number of catheter insertions, monitoring the inflammatory signs, and monitoring the lab data may be helpful to control the incidence of infection and decrease medical costs.
The most common complication of inserting a temporary hemodialysis catheter was catheter-related bloodstreaminfections (CRB SIs). The purpose of this study was to control the CRBSIs effectively. This study incorporated with a cross-sectional design involving field observation and retrospective chart review for 9 months, collecting 101 cases. The CRBSIs rate was 9.35%. From 14 CRBSI cases collected, we found that the incidence of an abnormal insertion site was 71.4% and the average number of days for abnormal insertion site was 4.79±5.3 days. The incidence of fever was 85.7% and the average occurrence days for fever were 6±5.3 days. The result showed that an increased number of catheter insertions, corresponded to higher WBC data before catheter removal and higher incidence of a fever episode, making a significant statistical difference between the CRBSIs and non-CRBSIs group (p<.05). The average length of stay for CRBSIs was 7.8 days longer than non-CRBSIs group. Therefore, controlling the number of catheter insertions, monitoring the inflammatory signs, and monitoring the lab data may be helpful to control the incidence of infection and decrease medical costs.